Related Experiment Video
Updated: Jul 19, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Clinical implications of prostate-specific antigen (PSA)
1Department of Urology, Royal Hallamshire Hospital, Sheffield S11 7JZ, UK.
Abstract:
Prostate-specific antigen(PSA) is currently the tumour marker of choice for prostatic carcinoma. This article examines the current literature on the application of PSA for cancer detection (concentrating on values of PSA in the normal and 'grey' areas of 2.5-10 ng/ml), in staging of the disease and prediction of treatment response. These areas in particular have been refined by the use of PSA indices (PSA density, velocity, age ranges) and the article focuses on the recent studies analysing their standing in clinical practice.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
